ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
US Tech 100
20,263.20
-1.69%
Dow Jones
41,938.45
-1.63%
Brent Oil
79.285
0.00%
Bitcoin
94,516.86
-0.20%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Royalty Pharma PLC (RPRX)

  7. Royalty Pharma PLC (RPRX) News

RPRX

Royalty Pharma (RPRX)

Royalty Pharma PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RPRX
DateTimeSourceHeadlineSymbolCompany
01/10/20255:26PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RPRXRoyalty Pharma PLC
01/10/20255:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
01/10/20257:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
01/10/20257:30AMGlobeNewswire Inc.Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
01/10/20257:15AMGlobeNewswire Inc.Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase ProgramNASDAQ:RPRXRoyalty Pharma PLC
01/09/20254:15PMGlobeNewswire Inc.Royalty Pharma Announces Dividend IncreaseNASDAQ:RPRXRoyalty Pharma PLC
12/31/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
11/27/20244:15PMGlobeNewswire Inc.Royalty Pharma to Present at Upcoming Investor ConferencesNASDAQ:RPRXRoyalty Pharma PLC
11/14/20244:30PMGlobeNewswire Inc.Royalty Pharma Announces Inaugural Prize for Impact in HealthcareNASDAQ:RPRXRoyalty Pharma PLC
11/07/20247:10AMGlobeNewswire Inc.Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 MillionNASDAQ:RPRXRoyalty Pharma PLC
11/06/20249:24AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPRXRoyalty Pharma PLC
11/06/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
11/06/20247:15AMGlobeNewswire Inc.Royalty Pharma Reports Third Quarter 2024 ResultsNASDAQ:RPRXRoyalty Pharma PLC
11/04/20244:15PMGlobeNewswire Inc.Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for NiktimvoNASDAQ:RPRXRoyalty Pharma PLC
11/04/20244:01PMPR Newswire (US)Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™NASDAQ:RPRXRoyalty Pharma PLC
10/16/20244:15PMGlobeNewswire Inc.Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:RPRXRoyalty Pharma PLC
10/11/20248:15AMGlobeNewswire Inc.Royalty Pharma Declares Fourth Quarter 2024 DividendNASDAQ:RPRXRoyalty Pharma PLC
09/27/20248:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
09/03/20245:14PMGlobeNewswire Inc.Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
09/03/20245:06PMGlobeNewswire Inc.Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
08/28/20244:15PMGlobeNewswire Inc.Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
08/12/20247:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
08/12/20247:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
08/12/20247:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
08/08/20249:02AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPRXRoyalty Pharma PLC
08/08/20247:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
08/08/20247:00AMGlobeNewswire Inc.Royalty Pharma Reports Second Quarter 2024 ResultsNASDAQ:RPRXRoyalty Pharma PLC
08/07/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
07/29/20244:30PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RPRXRoyalty Pharma PLC
07/24/20248:30AMGlobeNewswire Inc.Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human CapitalNASDAQ:RPRXRoyalty Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:RPRX

Your Recent History

AMEX
SPY
SPDR S&P 500
USOTC
NLST
Netlist (QB)
NASDAQ
MULN
Mullen Automotive
USOTC
NBRI
North Bay Resources (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
RNVA
Rennova Health (CE)
NASDAQ
ILLR
Triller
USOTC
GCAN
Greater Cannabis (PK)
USOTC
HIRU
Hiru (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
MONI
Moon Equity (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
PSRU
Valiant Eagle (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads